10x Insights
Loading account…
Companies / Healthcare / 908 Devices Inc.
MASS

908 Devices Inc.

HealthcareMedical Instruments
Ticker MASSBURLINGTON, MAFiscal year ends DecemberBook value per share $3.40Diluted shares 37.3M

Nine Hundred Eight Devices Inc. (NASDAQ: PHMD) is a technology company that designs, manufactures, and commercializes handheld devices for point-of-need chemical analysis. The company's website is www.908devices.com. From the company’s description.

Fiscal year 2025 · ends 12-31Changes are against fiscal 2024The amber dot is the latest twelve months, to 2026-06-30
Sales & profitability
$56.20M
−5.8% year over year
Last 12 mo $60.84M
-70.15%
+58.5 percentage points
Last 12 mo -63.99%
$19.49M
+127.0% year over year
Last 12 mo $-34.66M
13.56%
+41 percentage points
Last 12 mo -27.34%
Cash & financing
$-23.69M
+21.7% year over year
Last 12 mo $1.49M
$-24.64M
+20.1% year over year
Last 12 mo $0.62M
—
35.9M
+5.3% year over year
Last 12 mo 37.3M

Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.

What 908 Devices Inc. does

In the company’s own words

Nine Hundred Eight Devices Inc. (NASDAQ: PHMD) is a technology company that designs, manufactures, and commercializes handheld devices for point-of-need chemical analysis. The company's website is www.908devices.com.

908 Devices has developed an innovative suite of purpose-built handheld instruments leveraging mass spectrometry and optical spectroscopy technologies combined with advanced analytics and machine learning to deliver laboratory-grade chemical analysis capabilities in portable, user-friendly formats. The company's core technology platform centers on proprietary microscale mass spectrometry, known as High-Pressure Mass Spec or HPMS, which enables devices that are approximately one thousand times smaller than conventional laboratory instruments while consuming significantly less power and maintaining comparable analytical performance.

The company's primary product portfolio includes the MX908, a handheld mass spectrometry device for analyzing solids, liquids, vapors, and aerosols; the XplorIR, an FTIR spectroscopy device for detecting gases and vapors; the ThreatID, a portable FTIR device for identifying gases, vapors, powders, and liquids; the ProtectIR, a compact FTIR device for solid and liquid analysis; and the VipIR, a three-in-one analyzer integrating FTIR and Raman spectroscopy technologies. The company also offers consumables including sampling swabs, extended warranty service plans, technical support through its Reachback program, and on-site training services.

908 Devices has sold more than 3,700 handheld devices to over 700 customers worldwide, including numerous domestic and foreign government agencies, law enforcement organizations, military units, and first responders. The company operates manufacturing facilities in Danbury, Connecticut, and precision machining operations in Stamford, Connecticut, and Georgetown, Massachusetts. As of December 31, 2025, the company employed 43 full-time research and development personnel, of which approximately 49 percent hold advanced degrees in science and engineering, and 35 people in sales, marketing, and support roles. The company distributes its products through a combination of direct sales force and more than 64 third-party channel partners across domestic and international markets.

Company details
Sector
Healthcare
Industry
Medical Instruments
Headquarters
BURLINGTON, MA
Fiscal year end
December
CIK
1555279
SIC
3826

Financial performance, year by year

Fiscal 2021–2025 · USD
$-85.51M$-45.60M$-5.68M$34.23M$74.14M20212022202320242025Last 12 moLast 12 monthsLast 12 months

The full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.

Ownership

Who owns 908 Devices Inc. — and what changed

Funds as of 2026Q2 · superinvestors as of 2026-06-30

114
funds hold it
0 of 35
superinvestors hold it
$71.95M
held by funds, at market
21.9%
of shares held by funds

Largest fund holders · 908 Devices Inc.’s weight in each

ARK Genomic Revolution ETF
ARKG · ARK ETF Trust
1.08%of fund net assets
Needham Aggressive Growth Fund
NEAGX · Needham Funds Inc
0.47%of fund net assets
VANGUARD TOTAL STOCK MARKET INDEX FUND
VTI · VANGUARD INDEX FUNDS
0.00%of fund net assets
iShares Russell 2000 ETF
IWM · iShares Trust
0.01%of fund net assets
First Eagle Small Cap Opportunity Fund
FESRX · First Eagle Funds
0.22%of fund net assets

Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.

Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.

Could not be determined for this company: bond issues.

Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.

Connected research

Put this business in context.

Compare this company with peers, find it in your funds and follow its financial history with your connected AI:

  • “How do 908 Devices Inc. and its peers compare on margins and cash generation over ten years?”
  • “Where did five years of 908 Devices Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
  • “What changed in 908 Devices Inc.'s last four quarterly filings that the numbers alone won't show?”
See how it works →All research tools with a subscription. Use your own AI account.